Home > Insider Trading > Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
91 - 100
Next >>

Were Hedge Funds Right About Embracing Regeneron Pharmaceuticals Inc (REGN)?

In this article we will check out the progression of hedge fund sentiment towards Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and determine whether it is a good investment right now.

Keep Reading →

October 26th, 2020 - Hedge Funds News

Hedge Funds Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

August 31st, 2020 - Hedge Funds News

Were Hedge Funds Right About Piling Into Regeneron Pharmaceuticals Inc (REGN)?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Keep Reading →

July 7th, 2020 - Hedge Funds News

Trumpdesivir: Operation Warp Speed, “Engage.”

The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (min.

Keep Reading →

May 31st, 2020 - Stock Analysis

Hedge Funds Aren't Done Buying Regeneron Pharmaceuticals Inc (REGN)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

May 30th, 2020 - Hedge Funds News

Should You Be Tempted To 'Sell' Regeneron Pharmaceuticals (REGN) Stock

Distillate Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Distillate Capital’s U.S. Fundamental Stability & Value (U.S.

Keep Reading →

May 28th, 2020 - Hedge Fund Investor Letters News

Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry

At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016.

Keep Reading →

May 18th, 2020 - Stock Analysis

Polen Capital is Bullish on Regeneron Pharmaceuticals (REGN) and MSCI (MSCI)

Polen Capital Management, LLC, an independently-owned global investment manager, recently published its first-quarter focus growth commentary – a copy of which can be downloaded here.

Keep Reading →

April 28th, 2020 - Hedge Fund Investor Letters

Hedge Fund and Insider Trading News: Anthony Scaramucci, Pierre Andurand, Howard Marks, East Lodge Capital, Regeneron Pharmaceuticals Inc (REGN), Siebert Financial Corp. (SIEB), and More

Hedge fund manager Ali Lumsden gained 73% the last time the mortgage-bond market went into meltdown. This time around, the veteran investor is on the wrong side of the crisis.

Keep Reading →

April 21st, 2020 - Hedge Funds Insider Trading